InvestorsHub Logo
Followers 6
Posts 601
Boards Moderated 0
Alias Born 09/05/2013

Re: Fitz1030 post# 53

Tuesday, 12/24/2019 11:34:57 AM

Tuesday, December 24, 2019 11:34:57 AM

Post# of 217
That's interesting, I had not been aware of the pfizer immuno trial. It would appear they are deep in a phase iii trial. That IMO is a threat 2 to 3 years out. Trials/new drugs(even in phase iii) take enormous amounts of time to become fruitful, and immuno drugs even longer due to re-imbursement issues. They are VERY expensive treatments, and if there are other effective treatments on the market, good luck getting insurance to cover it.

Just my take, but I still like apvo as its cheap here, and they have many other opportunities in the works!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APVO News